Nervenarzt最新文献_第6页

[Psychosocial crisis services-A special case of transsectoral healthcare]. [社会心理危机服务——跨部门保健的一个特例]。

IF 1.1 4区医学

Nervenarzt Pub Date : 2025-07-29 DOI: 10.1007/s00115-025-01863-1

Jürgen Zielasek, Tamara L Orschler, Mechthild Pott, Monika Schröder, Euphrosyne Gouzoulis-Mayfrank

{"title":"[Psychosocial crisis services-A special case of transsectoral healthcare].","authors":"Jürgen Zielasek, Tamara L Orschler, Mechthild Pott, Monika Schröder, Euphrosyne Gouzoulis-Mayfrank","doi":"10.1007/s00115-025-01863-1","DOIUrl":"10.1007/s00115-025-01863-1","url":null,"abstract":"Background: The psychosocial burden of the population is increasing and psychosocial crisis intervention teams already play an important supportive role in the care in some regions in Germany. A comprehensive description of existing psychosocial crisis services in Germany is lacking.Objective: Description of the experiences of selected psychosocial crisis services in Germany and development of a concept for the implementation of new psychosocial crisis services.Material and methods: A narrative synthesis of the experiences of established psychosocial crisis intervention services in Germany was carried out based on searches in the scientific literature, perusal of information available on the internet regarding the activities of existing services and conversations with their representatives. We developed an experience-based concept for psychosocial crisis services in Germany.Results: The search for scientific evidence in the literature showed only limited evidence for the efficacy of psychosocial crisis intervention services. There is a broad diversity of types of services and models of financing. Barriers and facilitators of the implementation of psychosocial crisis services could be identified. These were included in a modular, experience-based transsectoral concept for psychosocial crisis intervention services in Germany.Conclusion: An experience-based modular concept for the implementation of a mental health crisis intervention service was developed. The modularity facilitates the adaptation to local and regional needs and resources and can promote a broader implementation.","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144734947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Taxonomy of anxiety disorders-a comparison of ICD‑10 and ICD‑11. 焦虑障碍的分类——ICD - 10和ICD - 11的比较。

IF 1.1 4区医学

Nervenarzt Pub Date : 2025-07-29 DOI: 10.1007/s00115-025-01842-6

Katharina Domschke, Peter Zwanzger

{"title":"Taxonomy of anxiety disorders-a comparison of ICD‑10 and ICD‑11.","authors":"Katharina Domschke, Peter Zwanzger","doi":"10.1007/s00115-025-01842-6","DOIUrl":"10.1007/s00115-025-01842-6","url":null,"abstract":"With the introduction of the 11th revision of the World Health Organization International Statistical Classification of Diseases and Related Health Problems (ICD-11), structural and content-related adjustments to the diagnostic guidelines for anxiety disorders were made, which are presented in this review article. Previously classified as \"phobic disorders\" and \"other anxiety disorders\" within the group \"neurotic, stress-related, and somatoform disorders\", in ICD-11 \"anxiety- or fear-related disorders\" now constitute a separate group. The core diagnoses of agoraphobia, social anxiety disorder, specific phobia, panic disorder and generalized anxiety disorder are retained, with the modification that agoraphobia and panic disorder can now be diagnosed separately and comorbidly. Within the framework of the lifespan perspective, separation anxiety disorder and selective mutism have been moved to the group \"anxiety- or fear-related disorders\". The diagnosis \"mixed anxiety and depressive disorder\" is now classified as \"mixed depressive and anxiety disorder\" in the group \"affective disorders\". In accordance with the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM‑5), it is possible to code isolated panic attacks in addition to other mental or somatic disorders. Overall, ICD-11 follows the DSM‑5 classification of anxiety- and fear-related disorders in many respects. Furthermore, the omission of subcategorizations and a precise minimum number of required symptoms simplify the diagnostic criteria. Future studies will need to address questions regarding the diagnostic accuracy, clinical practicability and further operationalization of the ICD-11 diagnostic criteria for anxiety- or fear-related disorders.","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144734950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Severe disabling ballism after stroke-An interdisciplinary challenge for rehabilitation and outpatient neuropsychiatric care]. [中风后严重致残性弹道-康复和门诊神经精神护理的跨学科挑战]。

IF 1.1 4区医学

Nervenarzt Pub Date : 2025-07-28 DOI: 10.1007/s00115-025-01869-9

Hans-Jürgen Gdynia, Peter Schneiderat, Martin Hinterseer, Michael Ertl

引用次数: 0

[Procedural modalities of coercive treatment]. [强制治疗的程序模式]。

IF 0.9 4区医学

Nervenarzt Pub Date : 2025-07-24 DOI: 10.1007/s00115-025-01870-2

Thomas Pollmächer, Felizitas Schweitzer, Andreas Sarropoulos, Andreas Schuld

引用次数: 0

[The cannabinoid hyperemesis syndrome-A narrative review]. [大麻素呕吐综合征-叙述性回顾]。

IF 0.9 4区医学

Nervenarzt Pub Date : 2025-07-21 DOI: 10.1007/s00115-025-01864-0

Udo Bonnet

{"title":"[The cannabinoid hyperemesis syndrome-A narrative review].","authors":"Udo Bonnet","doi":"10.1007/s00115-025-01864-0","DOIUrl":"https://doi.org/10.1007/s00115-025-01864-0","url":null,"abstract":"Background: Until 25 years ago cyclic vomiting attacks under the chronic influence of cannabis were virtually unknown. Following the legalization of non-medical cannabis in North America and the associated increase in cannabis use, including high-potency strains, the number of patients there with cannabis-related cyclic vomiting is increasing. The ROME-IV criteria now define cannabis-induced cyclic vomiting as cannabinoid hyperemesis syndrome (CHS). This review aims to provide information about CHS, as an increase in cases is also to be expected in Germany following legalization.Method: Selective review article.Results: The CHS is most frequently registered in emergency departments. A clear differentiation between CHS and cyclic vomiting syndrome (CVS), in which one third of those affected also regularly use cannabis, is only possible by establishing full remission during a 6-12 month cannabis abstinence. Therefore, mixed forms of CVS and CHS are initially seen in emergency departments (suspected CHS), also with hidden life-threatening abdominal comorbidities. Severe vomiting can also lead to serious complications. The commonly used antiemetics often do not help. Hot showers and baths as well as i.m. haloperidol (5 mg) can provide acute relief from severe vomiting. Rubbing the abdomen with 0.075-0.1% capsaicin cream also has an antiemetic effect but less quickly.Discussion: In ROME-IV the CHS is nosologically considered a special variant of CVS. In particular, it is a specific cannabis-related, often severe physical disorder. As healing can only be achieved through sustained cannabis abstinence, suspected CHS in emergency departments is an interdisciplinary challenge for gastroenterology, neuropsychiatry and the addiction support system.","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144676346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Focus: forensic psychiatric commitment and solution approaches]. [焦点：法医精神病学承诺和解决方法]。

IF 0.9 4区医学

Nervenarzt Pub Date : 2025-07-09 DOI: 10.1007/s00115-025-01854-2

Jürgen L Müller, Matthias Koller

引用次数: 0

[Management of complex anxiety disorders-A case for inpatient treatment?] [复杂焦虑症的管理--住院治疗的案例？］

IF 0.9 4区医学

Nervenarzt Pub Date : 2025-07-01 Epub Date: 2024-11-14 DOI: 10.1007/s00115-024-01764-9

K Feldker-Kasperek, J Diemer, P Zwanzger

{"title":"[Management of complex anxiety disorders-A case for inpatient treatment?]","authors":"K Feldker-Kasperek, J Diemer, P Zwanzger","doi":"10.1007/s00115-024-01764-9","DOIUrl":"10.1007/s00115-024-01764-9","url":null,"abstract":"Background: Anxiety disorders are among the most frequent psychiatric disorders. Although the vast majority of patients in Germany are treated on an outpatient basis, anxiety disorders also play an important role in day care and inpatient care. Among other aspects, this is against the background of comorbidities, treatment-resistant courses or complications such as suicidal ideation.Material and methods: As part of an evaluation of the basic psychiatric documentation (BADO) data from 894 patients with anxiety disorders treated in a day care or inpatient setting in a German psychiatric community hospital were evaluated over a period of 7 years.Results: It was found that 89% of the patients had already been treated before admission and that 70% had been under medication prior to admission: patients with panic disorder made up the largest group of patients with 48%. On the date of admission 48% of patients had been treated with a selective serotonin reuptake inhibitor (SSRI) and 37% had received a benzodiazepine. Furthermore, 75% of the patients had psychiatric comorbidities. Somatic illnesses played an important role in 40% of the patients.Discussion: The present results underline that a significant proportion of patients with anxiety disorders also require inpatient or day care treatment. Most patients had been previously treated and had not responded to therapy in an outpatient setting. Possible consequences with respect to the optimization of outpatient treatment options and the need to maintain day care and inpatient resources for this patient group, are discussed.","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":"382-385"},"PeriodicalIF":0.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142631424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Digital diagnosis instruments-Validation of a self-rating on diagnosis confirmation]. [数字诊断仪器--诊断确认自我评分的验证]。

IF 0.9 4区医学

Nervenarzt Pub Date : 2025-07-01 Epub Date: 2024-11-06 DOI: 10.1007/s00115-024-01762-x

Madlen von Fintel, Steffen Moritz, Lea Schuurmans

引用次数: 0

[Pharmacotherapy of cognitive impairment in schizophrenia-Between hope and disappointment]. 精神分裂症患者认知障碍的药物治疗——介于希望与失望之间。

IF 0.9 4区医学

Nervenarzt Pub Date : 2025-07-01 Epub Date: 2025-06-05 DOI: 10.1007/s00115-025-01846-2

Michael Paulzen, Sermin Toto

引用次数: 0

Erratum zu: Psychedelika und Dissoziativa in der Psychiatrie: Herausforderungen in der Behandlung. 勘误：精神病学中的迷幻剂和解离剂：治疗中的挑战。